Regenerative medicine requires diagnostics and product characterization beyond stem cell basics

Stem cell therapies are often portrayed as a single treatment, but they actually vary widely in tissue source, cell passage, viability and delivery methods.

Experts say a credible regenerative approach must incorporate diagnostics, detailed product characterization, and the patient’s underlying biology to determine who should receive which therapy.

Clinics are urged to build clinical models that capture these nuances, linking manufacturing information with conventional medical assessment to provide a holistic view of patient health.